NCT02888652View on ClinicalTrials.gov

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

October 31, 2018

Conditions
Coronary Heart Disease
Interventions
DRUG

antiplatelet agents(Clopidogrel or Ticagrelor)

Clinical physicians according to patients condition to give different antiplatelet agents(Clopidogrel or Ticagrelor).We only observe clinical curative effect.

Trial Locations (1)

410013

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

The Third Xiangya Hospital of Central South University

OTHER

NCT02888652 - Study on the Registration of Coronary Heart Disease Patients Undergoing PCI | Biotech Hunter | Biotech Hunter